Skip to content

Clinical trials

Phase 1 Urinary Bladder Neoplasms trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urinary Bladder Neoplasms Phase: Phase 1 Country / region: France Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20112
20132
20152
20181
20193
20202
20214
20221
20231
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting5
Terminated5
Active, not recruiting2
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company4
Bayer2
Institut Cancerologie de l'Ouest2
Pfizer2
Astellas Pharma Global Development, Inc.1
Black Diamond Therapeutics, Inc.1
Celgene1
Centre Georges Francois Leclerc1
Daiichi Sankyo1
EMD Serono Research & Development Institute, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urinary Bladder Neoplasms24
Carcinoma, Non-Small-Cell Lung12
Ovarian Neoplasms9
Squamous Cell Carcinoma of Head and Neck8
Stomach Neoplasms6
Uterine Cervical Neoplasms6
Carcinoma, Renal Cell5
Carcinoma, Transitional Cell5
Melanoma5
Neoplasm Metastasis5

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.